Clinical Trial

Heparin Alone vs. Heparin-Aspirin Combo in Free Flap Survival

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This randomized clinical trial aims to compare the effectiveness of heparin alone versus combination therapy of Heparin- Aspirin in improving free flap survival in patients undergoing reconstructive surgery. Participants will be randomly assigned to receive either heparin or a combination therapy, and the primary outcome measure will be the survival rate of the free flap at various time points post-surgery
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06512233
Lead Sponsor Aga Khan University
Conditions Complication,Postoperative
Enrollment 126 participants
Start Date 2025-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-23